1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
One Plus One Equals Two—will that do? A trial protocol for a Swedish multicentre randomised controlled trial to evaluate a clinical practice to reduce severe perineal trauma {1}
(
- Contribution to journal › Article
- 2015
-
Mark
Little difference between minimum inhibitory concentrations of Mycobacterium tuberculosis wild-type organisms determined with BACTEC MGIT 960 and Middlebrook 7H10.
(
- Contribution to journal › Article
- 2014
-
Mark
Evaluation of intra- and extracellular activity of trimethoprim-sulfamethoxazole against susceptible and multidrug-resistant Mycobacterium tuberculosis.
(
- Contribution to journal › Article
- 2013
-
Mark
Proficiency of drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide: the Swedish experience
(
- Contribution to journal › Article
- 2012
-
Mark
Reevaluation of the Critical Concentration for Drug Susceptibility Testing of Mycobacterium tuberculosis against Pyrazinamide Using Wild-Type MIC Distributions and pncA Gene Sequencing
(
- Contribution to journal › Article
- 2011
-
Mark
Wild-type distributions of seven oral second-line drugs against Mycobacterium tuberculosis
(
- Contribution to journal › Article
- 2010
-
Mark
Wild-type MIC distributions of four fluoroquinolones active against Mycobacterium tuberculosis in relation to current critical concentrations and available pharmacokinetic and pharmacodynamic data
(
- Contribution to journal › Article